Literature DB >> 9065470

Cell type- and developmental stage-specific activation of NF-kappaB by fMet-Leu-Phe in myeloid cells.

D D Browning1, Z K Pan, E R Prossnitz, R D Ye.   

Abstract

Chemoattractants induce a variety of phagocytic functions including transendothelial migration, degranulation, and the generation of superoxide anions. We report here that the prototypic chemotactic peptide fMet-Leu-Phe (fMLF) stimulates the activation of nuclear factor-kappaB (NF-kappaB), a transcription factor that is central to the regulation of proinflammatory immediate-early gene expression. In freshly prepared peripheral blood mononuclear cells, fMLF (1-100 nM) induced a kappaB binding activity that was receptor-dependent and involved the p50 and p65 subunits of the NF-kappaB/Rel family of proteins. The activation of NF-kappaB by fMLF appeared to be cell-specific and different from the activation of NF-kappaB by tumor necrosis factor-alpha (TNFalpha). Neutrophil preparations that responded to fMLF, TNFalpha, and lipopolysaccharides with interleukin-8 secretion did not show NF-kappaB activation, whereas N-formyl peptide receptor (FPR)-transfected HL-60 cells were responsive to TNFalpha but not fMLF for NF-kappaB activation. Differentiation of FPR-transfected HL-60 cells with dimethyl sulfoxide for 3-5 days conferred the capability of the cells to activate NF-kappaB in response to fMLF without a significant increase in the amount of FPR. These results identify NF-kappaB as a transcription factor that can be activated by the prototypic chemotactic peptide and demonstrate that this function is both highly regulated and dependent on signaling components specifically expressed during myeloid differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065470     DOI: 10.1074/jbc.272.12.7995

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Synergistic activation of NF-{kappa}B by bacterial chemoattractant and TNF{alpha} is mediated by p38 MAPK-dependent RelA acetylation.

Authors:  Warren W Pan; Jain-Dong Li; Shuang Huang; Thomas J Papadimos; Zhixing K Pan; Ling-Yu Chen
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses.

Authors:  D K Hsu; R Y Yang; Z Pan; L Yu; D R Salomon; W P Fung-Leung; F T Liu
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Regulation and function of nuclear IκBα in inflammation and cancer.

Authors:  Ivana Vancurova; Ales Vancura
Journal:  Am J Clin Exp Immunol       Date:  2012-05-25

4.  Cysteinyl-glycine reduces mucosal proinflammatory cytokine response to fMLP in a parenterally-fed piglet model.

Authors:  Matthew G Nosworthy; Janet A Brunton
Journal:  Pediatr Res       Date:  2016-04-07       Impact factor: 3.756

5.  Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway.

Authors:  Sunil K Manna; Govindarajan T Ramesh
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

6.  PKC- and ERK-dependent activation of I kappa B kinase by lipopolysaccharide in macrophages: enhancement by P2Y receptor-mediated CaMK activation.

Authors:  B C Chen; W W Lin
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

7.  Adaptor protein-2 interaction with arrestin regulates GPCR recycling and apoptosis.

Authors:  Brant M Wagener; Nicole A Marjon; Chetana M Revankar; Eric R Prossnitz
Journal:  Traffic       Date:  2009-06-15       Impact factor: 6.215

8.  NFkappaB is persistently activated in continuously stimulated human neutrophils.

Authors:  Veronika Miskolci; Janet Rollins; Hai Yen Vu; Chandra C Ghosh; Dennis Davidson; Ivana Vancurova
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

Review 9.  Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression.

Authors:  Jian Huang; Keqiang Chen; Wanghua Gong; Ye Zhou; Yingying Le; Xiuwu Bian; Ji Ming Wang
Journal:  Cancer Lett       Date:  2008-04-22       Impact factor: 8.679

10.  PPM1A is a RelA phosphatase with tumor suppressor-like activity.

Authors:  X Lu; H An; R Jin; M Zou; Y Guo; P-F Su; D Liu; Y Shyr; W G Yarbrough
Journal:  Oncogene       Date:  2013-07-01       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.